Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia.
Riccardo MoiaMariangela GrecoPaola BoggioneMaura NicolosiRiccardo BrunaAndrea PatriarcaGianluca GaidanoMonia LunghiPublished in: Clinical case reports (2020)
Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.